Clinical Trials
63 trialsFOCUS
Ohio State University Comprehensive Cancer Center
Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).
Casa di Cura Dott. Pederzoli
HOPE
Cognito Therapeutics, Inc.
FEAD
Helse Stavanger HF
Implement and Test Visual Consent Template and Process
Washington University School of Medicine
XanaMIA
Actinogen Medical
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Evaluation of a Mobile App Program for Coping With Cancer
Yale University
LETSGO
Sorlandet Hospital HF
PsyMINT
Virginia Commonwealth University
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Weill Medical College of Cornell University
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
EVANTHEA
Alzheimer's Prevention and Reversal Project, Inc.
Evaluation of a Self-compassion App in People With Cancer: Feasibility, Acceptability and Changes in Well-being
University Medical Center Groningen
ALDH2 Genetic Testing in East Asian Community
Northwestern University
Tau PET Outcomes With Anti-amyloid Immunotherapies
Mayo Clinic
PRO2
Palleos Healthcare GmbH
DECAD
Indiana University
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
University of Pennsylvania
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Biograph Vision 600 Versus Biograph Vision.X PET/CT
University Hospital, Geneva
PSHW
PROSOMNIA Sleep Health & Wellness
A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain
Janssen Research & Development, LLC
Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial
Oslo University Hospital
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Alzinova AB
Engagement and Acceptability of the Untire mHealth App
University of Bath
SmartPrompt
Temple University
VKI
Temple University
Paper-Based and Smartphone-Based Memory Supports
Baylor University
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Cognito Therapeutics, Inc.
S-DeciDeD
Maastricht University
HYDEM
Central Hospital, Nancy, France
ICE
Centre Hospitalier Universitaire de Besancon
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Massachusetts General Hospital
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
Inmune Bio, Inc.
Choko-AGE
Universita di Verona
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
STARR
Weill Medical College of Cornell University
YOUEX
University Hospital Heidelberg
PACEinMM-QC
Université de Sherbrooke
STRATEGIES to Improve Memory in Alzheimer's Disease
Boston University
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
Icahn School of Medicine at Mount Sinai
Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care
National Taipei University of Nursing and Health Sciences
OLFADIAG
Nouvelle Clinique Bonnefon
V-iCST
University College, London
AMYLOCARP
Ramsay Générale de Santé
Overture
Cognito Therapeutics, Inc.
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Cognito Therapeutics, Inc.
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Boston Medical Center